Yupred 4 Tablet contains Methylprednisolone 4 mg, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, allergic reactions, asthma, and certain dermatological disorders. Methylprednisolone exerts its effects by modulating the immune response and inhibiting the release of inflammatory mediators, thereby reducing swelling, redness, and pain. Yupred 4 is also utilized in the treatment of adrenal insufficiency and as adjunct therapy in certain hematologic and oncologic conditions. The dosage and duration of treatment with Yupred 4 Tablet should be individualized based on the patient’s clinical condition, response to therapy, and underlying disease severity. It is essential to administer this medication under strict medical supervision due to potential side effects, including immunosuppression, hyperglycemia, osteoporosis, and adrenal suppression. Abrupt discontinuation should be avoided to prevent withdrawal symptoms. Patients should be monitored regularly for adverse effects and therapeutic efficacy. Yupred 4 Tablet is contraindicated in systemic fungal infections and should be used cautiously in patients with diabetes, hypertension, or peptic ulcer disease.